Skip Navigation

'It is a game changer' — Cramer says Merck's new Covid pill could send stock even higher

Published Fri, Oct 1 202110:29 AM EDTUpdated Fri, Oct 1 202110:55 AM EDT

Matthew J. Belvedere @Matt_Belvedere

Jim Cramer on CNBC's Halftime Report.

Scott Mlyn | CNBC

Shares of Merck, soaring on encouraging trial data on the drugmaker's new Covid pill, could "conceivably go higher," CNBC's Jim Cramer said Friday.

More In CNBC TV Picks

Tom Lee says the bar is lower for the Fed to cut and so stocks are set to do ‘quite well’

Tom Lee says the bar is lower for the Fed to cut and so stocks are set to do ‘quite well’

Lisa Kailai Han

Fed rate cuts will only come when the economy really needs them, Cantor Fitzgerald CEO says

Fed rate cuts will only come when the economy really needs them, Cantor Fitzgerald CEO says

Big bank executives will assure lawmakers the industry's crisis is over, KBW CEO Thomas Michaud predicts

Big bank executives will assure lawmakers the industry's crisis is over, KBW CEO Thomas Michaud predicts

Stephanie Landsman